Tools and Information for You, Your Practice and Your Patients
We are committed to providing you and your veterinary clinic staff with the latest clinical studies, tools for identifying inappetence in your canine patients and using ENTYCE® (capromorelin oral solution), as well as professional education opportunities to help you stay informed.
Your convenient one-stop source for viewing important information.
Valuable tools for recognizing inappetence and using ENTYCE to stimulate appetite in canine patients.
Upcoming conferences and online education to stay informed about managing inappetence.
IMPORTANT SAFETY INFORMATION: ENTYCE® (capromorelin oral solution) is for use in dogs only. Do not use in breeding, pregnant or lactating dogs. Use with caution in dogs with hepatic dysfunction or renal insufficiency. Adverse reactions in dogs may include diarrhea, vomiting, polydipsia, and hypersalivation. Should not be used in dogs that have a hypersensitivity to capromorelin. Please see the full Prescribing Information for more detail.
Other therapeutics from Aratana
NOCITA® (bupivacaine liposome injectable suspension) is the only long-acting local anesthetic that controls cranial cruciate ligament (CCL) post-op pain with one dose for up to 72 hours.
You can be sure that the local relief will help keep your patient is comfortable even after going home.
IMPORTANT SAFETY INFORMATION: NOCITA® (bupivacaine liposome injectable suspension) is for use in dogs only. Do not use in dogs younger than 5 months of age, dogs used for breeding, or in pregnant or lactating dogs. Do not administer by intravenous or intra-arterial injection. Adverse reactions in dogs may include discharge from incision, incisional inflammation and vomiting. Avoid concurrent use with bupivacaine HCl, lidocaine or other amide local anesthetics. Please see the full Prescribing Information for more detail.